Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This flat-rate model removes cost barriers to dose optimization, allowing your clinician to adjust your injection strength based on your individual tolerance and response rather than price concerns
Unlike traditional medications such as semaglutide (Wegovy, Ozempic) or liraglutide (Saxenda, Victoza)which only target the glucagon-like peptide-1 (GLP-1) receptortirzepatide is a dual agonist
Not approved for medical, diagnostic, or therapeutic applications
Despite favorable effects of tirzepatide on a range of cardiovascular risk factors, to date its cardiovascular safety has been reported from results of only a single trial, SURPASS-4 (ref
Experience was seamless and very happy with the product All shipping was quick and professional
US$ 25.25
US$ 24.45
US$ 27.80
